Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are suspected of having a condition called Chronic Thromboembolic Pulmonary Hypertension (CTEPH), where old blood clots cause high blood pressure in the lungs, based on results from specific breathing/heart scans that are consistent with this diagnosis (following French medical guidelines)
- People whose doctors have determined they need a procedure called a right heart catheterization, where a thin tube is used to measure pressure inside the heart and lungs
- People who are covered by French social security (or an equivalent plan)
- People who have been fully informed about the study and have agreed to take part
Who may not be able to join:
- People whose lung scan results show normal blood flow through the lungs (no signs of blockage)
- People who are under legal guardianship
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laurent BERTOLETTI, PhD, Centre Hospitalier Universitaire de Saint Etienne
Phone: (0)477127770
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proteomic pattern associated with the diagnosis of Chronic thromboembolic pulmonary hypertension (CTEPH)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.